Skip to main content

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall

 

Tenn Canna Publishing

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall





How HHS and FDA medical evaluations clash with DEA inaction — a modern battle of words in federal cannabis policy.

Read the series from the beginning: Reefer Madness 2.0: The War of Words Begins

HHS / FDA Scientific Findings

On August 29, 2023, the Department of Health and Human Services (HHS) submitted a scientific evaluation recommending that cannabis be rescheduled to Schedule III. The report stated:

“HHS … found that marijuana has a potential for abuse less than the drugs or other substances in Schedules I and II; that marijuana has a currently accepted medical use; and that the abuse of marijuana may lead to moderate or low physical dependence or high psychological dependence.”
— HHS Scientific Evaluation Letter to DEA, 2023

This was a clear, evidence-based recommendation supporting medical use. Modern research and decades of state legalization programs confirm these findings.

DEA / Enforcement Reality

Despite the HHS recommendations, the DEA continues to maintain that cannabis has “no currently accepted medical use,” creating a direct conflict between science and policy:

“Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis)… Schedule I drugs … are defined as drugs with no currently accepted medical use and a high potential for abuse.”
— DEA Drug Scheduling, 2025

Recent reporting highlights the ongoing stall:

“The Drug Enforcement Administration said … the marijuana rescheduling process remains stalled … despite the head of agency’s prior commitment to senators that he would prioritize the issue if confirmed for the role.”
— Marijuana Moment, 2025
“Marijuana has been ‘legalized’ and/or ‘decriminalized’ at the state level … as of January 2024 …”
— DEA 2025 National Drug Review

War of Words: Highlighting Contradictions

  • HHS: “Currently accepted medical use.”
    DEA: “No accepted medical use.”
  • HHS: “Abuse potential is lower than Schedule I/II drugs.”
    DEA: “High potential for abuse.”
  • HHS: “Rescheduling recommended.”
    DEA: “Process remains stalled.”

By letting their own words collide, the contradictions are clear — the science is settled, yet the gatekeepers remain in stasis.

Actionable Angle for Readers

  • Track official HHS/FDA reports vs. DEA statements.
  • Compare federal contradictions with real-world state legalization outcomes.
  • Document and share clear “War of Words” examples to expose the gap between evidence and enforcement.

Next in the Series

Attorney General / Executive Branch: Who has the final say on scheduling, the political leverage points, and how their statements reveal obstacles to reform.

🧭 Explore Tennessee Cannabiz Related Posts

© Tenn Canna Publishing — Reefer Madness 2.0 Series | Author: Tenn Canna Publishing

Labels:

Comments

Post a Comment

People's Choice

Free the Green: A Plea for Federal Marijuana Rescheduling

Cannabis Plea For Presidential Clemency Free the Green: A Plea for Federal Marijuana Rescheduling Tennessee has already shown us what happens when entrenched interests and moral gatekeepers get to decide the fate of cannabis. High-THCA hemp is being outlawed, alcohol profiteers are cementing control over legal hemp, and private prisons still profit from outdated laws. The result? Ordinary citizens and small businesses are punished, while special interests thrive. The Holier-Than-Thou Interference Too often, policy is driven not by science or fairness, but by people and organizations who think they know better than everyone else. Regulators, politicians, and industry lobbyists have allowed personal biases and financial incentives to dictate what Americans can grow, sell, or consume. THCA bans, complex licensing systems, and arbitrary enforcement all prove the point: when marijuana is scheduled federally as it is now, interference from outsiders rules the day. Why Rescheduling Ma...
Post a Comment
Read more

What is Delta 9?

Delta-9 refers to delta-9-tetrahydrocannabinol , commonly known as THC . Not a Delta 9 Compound-but it looks cool. THC is the primary psychoactive compound found in cannabis that is responsible for the "high" or intoxicating effects when consumed. Delta-9 specifically refers to the specific position of a double bond in the THC molecule. It is the most well-known and studied cannabinoid in cannabis and is what gives marijuana its euphoric and mind-altering properties. When people talk about THC in cannabis, they are usually referring to delta-9-THC. 🧭 Explore Tennessee Cannabiz 🛞 Series Master Hub
Post a Comment
Read more

Optimizing the Decarboxylation process to Achieve the Desired THC Potency?

 When optimizing the decarboxylation process to achieve the desired THC potency, there are several key factors to consider: Heating the THCA CANNABIS 1. Temperature :  • Higher temperatures (above 300°F/150°C) can lead to faster decarboxylation but also increase the risk of over-decarboxylation and potential degradation of THC. • The optimal temperature range is typically between 220-245°F (105-118°C) for complete decarboxylation while preserving THC potency. 2. Time: • Longer exposure to heat results in more complete decarboxylation, but too much time can lead to THC degradation. • The ideal decarboxylation time is usually between 30-60 minutes, depending on the temperature used. 3. Moisture Content: • Cannabis with higher moisture content may require longer decarboxylation times to achieve the same level of THC conversion. • Drying the cannabis prior to decarboxylation can help improve the efficiency of the process. 4. Cannabis Strain and Cannabinoid Profile: • Different can...
Post a Comment
Read more

Endocannabinoid System Explained: How Your Body Responds to Cannabis Naturally

  Endocannabinoid System Explained: How Your Body Responds to Cannabis Naturally Meta Description: Discover how your endocannabinoid system (ECS) works, why it’s called the body’s natural cannabis system, and how it affects mood, sleep, appetite, and more. What the Heck is the Endocannabinoid System? Your Endocannabinoid System Think of your body as a high-tech network, buzzing with messages and signals. The endocannabinoid system (ECS) is like the secret Wi-Fi that keeps everything balanced. Scientists only discovered it in the 1990s, but it’s been running your body behind the scenes all along. Your ECS is made up of three key components: Receptors (CB1 and CB2) – The “antennae” on your cells that detect cannabinoids. Endocannabinoids – Your body’s own natural cannabis molecules. Enzymes – The clean-up crew that breaks down cannabinoids when they’ve done their job. Why Should You Care? Your ECS affects almost everything: Mood & stress – K...
Post a Comment
Read more

Cannabis and the Endocannabinoid System: Legalization, Benefits, and Research

Cannabis and the Endocannabinoid System: Legalization, Benefits, and Research Meta Description: Learn how cannabis interacts with your endocannabinoid system (ECS), the benefits of THC and CBD , and how legalization trends are shaping research and access to cannabinoids. Cannabinoid Receptors: Science & Legalization Why Your ECS Loves Cannabis Your endocannabinoid system (ECS) is built to interact with cannabinoids, whether they come from your body or the cannabis plant. Cannabis contains over 100 cannabinoids, with THC and CBD being the most well-known. THC: Binds mainly to CB1 receptors in the brain, producing euphoria, altered perception, and relaxation. CBD: Interacts with CB2 receptors and modulates CB1 activity, helping reduce inflammation , pain, and anxiety without a psychoactive high . Benefits of Cannabis Through the ECS When used responsibly, cannabinoids can support: Stress relief and mood regulation Pain and inflammation managem...
Post a Comment
Read more